A new light on antibiotic resistance

Using the power of genomics and informatics to fight antibiotic-resistant microbes

Optimizing Genomic Testing for Antibiotic Resistance


Existing tests can take days to identify the correct treatment for a patient’s infection. That’s why caregivers often use broad-spectrum antibiotics as a first defense—but when those drugs are overused, antibiotic-resistant microbes can emerge. OpGen is developing a better way to treat infection while preventing antibiotic resistance. We harness the power of informatics and genomics to identify antimicrobial resistant (AMR) organisms quickly and accurately, with an aim to improve treatment at the patient, hospital, and network level.

Bacteria
700,000

Deaths each year from bacterial infections (WHO)

50,000

Deaths annually in the us & europe from drug-resistant infections

$20 billion

Excess direct healthcare costs in the us from drug-resistant infections

RNA

In The News

OpGen’s Bet on Precision Antibiotics - Wendy Diller

Learn More

antimicrobial agents

Publications

OpGen accurately and reliably predicts antibiotic resistance in comprehensive study

Read More

Forbes logo

In The News

OpGen is helping New York fight antimicrobial resistance with technology.

Read More

Latest News

  • 8.07.19
    OpGen Reports Second Quarter 2019 Financial Results and Provides Business Update  MORE
  • 7.30.19
    OpGen Announces Date of Second Quarter 2019 Financial Results Conference Call  MORE
  • 6.27.19
    OpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy  MORE

See all news

Upcoming Events

  • October 2 - 6, 2019
    IDWeek  MORE

See all events

Latest Blog Posts

  • 7.22.19
    New Research Sheds Light on Community-Acquired ESBL UTIs  MORE

See blog

Contact Us

For more information on our products and services
  • This field is for validation purposes and should be left unchanged.